Administrative intervention to support testing after gestational diabetes and hypertensive disorders in pregnancy

Not Applicable

Recruiting

• Conditions: Gestational diabetes mellitus; Hypertensive disorder in pregnancy; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy; Metabolic and Endocrine - Diabetes; Cardiovascular - Hypertension

• Registration Number: ACTRN12624000819527
• Lead Sponsor: Prof Michelle Giles, Department of Obstetrics, Monash Health, 246 Clayton Road, Melbourne, Vic 3168

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-03
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 144

Inclusion Criteria

Planning to receive all antenatal care at site of study recruitment
Diagnosed with HDP or GDM at any point during pregnancy

Exclusion Criteria

Aged <18 years
Past history of hypertension, Type 1 or Type 2 diabetes or Mature Onset Diabetes of the Young (MODY) that predates current pregnancy and for which they receive long term healthcare follow up
Diagnosis of severe GDM or HDP with activation of alternative specialist postpartum pathways: endocrinologist (GDM with complex management needs or concern for pre-existing Type 1 diabetes or MODY); or nephrologist (severe pre-eclampsia, eclampsia, or Haemolysis/Elevated Liver enzymes/Low platelets HELLP syndrome).
Residence interstate/overseas and planning to complete postpartum care outside of Victoria.
Women who have had a fetal death in utero or stillbirth; if already recruited, then they will automatically be withdrawn from the study.
Women who have complex medical or psychiatric needs in the peripartum period requiring extended stay (> two weeks, or > one week in Intensive Care Unit) postpartum; or otherwise deemed unsuitable at the discretion of the researcher/clinician.
Women who are incarcerated, who do not speak English and there is no interpreter available to obtain consent
Women who give birth prior to 32 weeks where an alternate postpartum pathway is in situ for follow-up

Study & Design

• Study Type: Interventional
• Study Design: Not specified